Neurogene Inc.
NGNE
$16.80
-$0.98-5.51%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 3.44% | 17.13% | |||
| Gross Profit | -9.89% | -10.25% | |||
| SG&A Expenses | 10.91% | 1.47% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.32% | 12.74% | |||
| Operating Income | -10.16% | -7.79% | |||
| Income Before Tax | -9.33% | -9.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -9.33% | -9.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.33% | -9.28% | |||
| EBIT | -10.16% | -7.79% | |||
| EBITDA | -10.64% | -8.19% | |||
| EPS Basic | -9.25% | -9.04% | |||
| Normalized Basic EPS | -9.25% | -9.70% | |||
| EPS Diluted | -9.25% | -9.04% | |||
| Normalized Diluted EPS | -9.25% | -9.70% | |||
| Average Basic Shares Outstanding | 0.07% | 0.22% | |||
| Average Diluted Shares Outstanding | 0.07% | 0.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
